Edwards Lifesciences (EW) executive Chopra gave up 398 shares at $86.77 to cover taxes or an exercise price
Insider transactions reported
Daveen Chopra (CVP, TMTT, Surgical & IHFM at Edwards Lifesciences Corporation, EW) reported that they gave up 398 shares at $86.77 to cover taxes or an exercise price on Sep 11, 2026. After these transactions the filing shows 43,926 shares held directly.
- Reporting person
- Chopra Daveen
- Role
- CVP, TMTT, Surgical & IHFM
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Shares withheld for taxes or exercise price (F) | Common Stock1 | -398 | $86.77 | $34.5K | 43,926 direct |
Holdings before and after
- Common Stock: 44,324 to 43,926 direct
Footnotes from the filing
- 1. Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Chopra report in this EW Form 4?
Daveen Chopra (CVP, TMTT, Surgical & IHFM at Edwards Lifesciences Corporation, EW) reported that they gave up 398 shares at $86.77 to cover taxes or an exercise price on Sep 11, 2026. After these transactions the filing shows 43,926 shares held directly.
How many EW shares does Chopra hold after this filing?
The filing shows 43,926 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for EW
Across the 27 sessions after earlier EW headlines, the stock closed higher 14 times and lower 13 times, with a median move of 0.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | EW | SPY |
|---|---|---|---|
| Sep 11, 2026 | Edwards Lifesciences Comments on TAVR National Coverage Decision | -2.8% | +0.9% |
| Sep 3, 2026 | Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit | -1.1% | +1.0% |
| Jul 28, 2026 | UBS initiated coverage on Edwards Lifesciences with a new price target | +0.8% | +0.2% |
| Jul 24, 2026 | Edwards Lifesciences upgraded by Leerink Partners with a new price targetand 1 other headline that session | -1.4% | +0.1% |
| Jul 16, 2026 | Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026 | +0.7% | -0.5% |
| Jun 26, 2026 | Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves | +1.2% | -0.7% |
Earlier insider filings at EW
- Aug 31, 2026SVP, Corporate Controller Dahl Andrew M. sold $49,534 worth of shares (544 units at $91.06), decreasing direct ownership by 4% to 14,868 units (SEC Form 4)
- Aug 28, 2026CVP, EMEACLA Bruls Annette sold $237,907 worth of shares (2,644 units at $89.98), decreasing direct ownership by 13% to 17,984 units (SEC Form 4)
- Aug 26, 2026CVP, TMTT, Surgical & IHFM Chopra Daveen exercised 31,800 shares at a strike of $72.68 and sold $2,894,440 worth of shares (31,800 units at $91.02) (SEC Form 4)
- Aug 26, 2026CVP, JAPAC Markowitz Wayne sold $113,417 worth of shares (1,240 units at $91.47), decreasing direct ownership by 6% to 20,294 units (SEC Form 4)
- Aug 11, 2026CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Industrial Specialties
Follow EW and get a push notification the moment its next story breaks.